Bob Chisholm TQMS STATISTICALLY BASED IN-PROCESS CONTROL WITH REAL TIME QUALITY ASSURANCE The AstraZeneca Total Quality Management Strategy R S Chisholm.

Slides:



Advertisements
Similar presentations
Producing a Pharmaceutical or Biopharmaceutical
Advertisements

Handheld Raman Spectrometer
Statistical Approaches to Addressing the Requirements of the New FDA Process Validation Guidance for Small Molecules 1 Jason Marlin, MS/T Statistics, Eli.
Satish Mallya January 20-22, |1 | 3-1. Assessing Batch Records Satish Mallya Quality Workshop, Copenhagen May 18-21,2014 May 18-21,2014.
© 2013 IBM Corporation Tivoli and Maximo Quality Improvement Initiatives March 2014.
Manufacturing Process
Supplier SQM Participation. 2 | MDT Confidential What is SQM? Stands for Supplier Quality Managment –Formally referred to as SPACE and SPICE Is a system.
Pharmtech Contract Services Offered by the Division of Pharmaceutical Technology.
Quality by Design (QbD) in Product Development
Clyde Rogers 1 Continuous Monitoring Continuous Auditing Organizational Readiness What Needs To Be Done Making It Happen.
Australian Centre for Field Robotics, University of Sydney Performance Measures and Validation for Systems of Decentralised/Distributed UAS Salah Sukkarieh.
Oman Energy & Water Conference Exhibition May 19-21, 2015
Quality control of raw materials In-process control
Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline.
EVALUATION SEMINAR PRESENTATION
Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.
Robust and affordable process control technologies for improving standards and optimising industrial operations Pau Puigdollers Project Coordinator.
By: Muhammad Naeem Quality Assurance and Regulatory Manager
An Industry Perspective on the Potential for Emerging Process Analytical Technologies Norman Winskill Steve Hammond Pfizer Global Manufacturing Services.
LIFE SCIENCES Pharmaceutical Manufacturing Chemical & Biosciences Technology QA/QC in Pharmaceutical Industry Applied Biology & Chemistry.
Sterling Healthcare Limited ( A Sandesara Group Company) Company Presentation 4/19/2017.
World Health Organization
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Learnings from Pre-approval Joint Inspection of a GSK QbD Product with US-FDA & EMA and the application of Continuous Verification 17 May 2011, Beijing,
A Seminar on 1.  Why to validate?  Parts of Equipment Validation  Who should do Equipment Validation?  Equipment qualification  Typical process flow.
Figure 3: Process fingerprint monitoring of a bio- reactor Biopharm production methods need effective real-time monitoring and control to guarantee a low-cost,
1 PCR Quality Assurance and Testing Protocol (Draft Version) Dr. Joseph Greene CSU, Chico June 24, 2004.
Case Studies in Change Management IFF February 2009.
Quality Control Testing in Procurement Helene Möller, M.Pharm, PhD Interregional Seminar for Quality Control Laboratories involved in WHO Prequalification.
Total Quality Management System (TQMS) AstraZeneca Solid Dosage Facility, Plankstadt, Germany Ali Afnan AstraZeneca Pharmaceuticals Engineering Group Alderley.
FDA Regulatory Perspective on Continuous Manufacturing
Applications and benefits of PAT Steve Hammond Global Manufacturing Services Process Analytical Support Group Sandwich, UK.
Helping the World Be Well through Innovative Manufacturing
Food And Drug Administration Science Advisory Board Meeting - Nov Pharmaceutical Industry - where to? More real time process control More real.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
D. Christopher Watts, Ph.D. Office of Pharmaceutical Science, CDER, FDA Science Seminar Series for the Office of Commissioner April 9, 2004 Process Analytical.
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
A Qualitative Decision Making Tool to Aid in Defining the Number of Lots for a Process Validation Campaign Leslie Sidor — Amgen Inc Midwest Biopharmaceutical.
Important informations
Corporate Support PPSO Gez Keating, Serco Plc. AGENDA Portfolio Management Role of Corporate PPSO Processes Where to Start Benefits.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
20 Oct 2004www.Torbeck.Org1 Impact of PAT on the Use of Statistics Lynn Torbeck
Small molecules Liquids – Solvent composition – Reactions – HME Dry Powder – Blending – Dry Granulation – Dry milling Wet solids – API Crystallization.
Molecule-to-Market-Place Quality
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
FDA PROCESS ANALYTICAL TECHNOLOGY SUB COMMITTEE MEETING 25 TH FEBRUARY 2002 PERSPECTIVE ON PROCESS AND ANALYTICAL VALIDATION Robert S Chisholm.
Open GSBPM compliant data processing system in Statistics Estonia (VAIS) 2011 MSIS Conference Maia Ennok Head of Data Warehouse Service Data Processing.
Validation Validation: A systematic study which ensures that systems, facilities and processes are working adequetly and precisely. Validation is an integral.
External Peer Review of the FDA Office of Regulatory Affairs Pesticide Program FDA Science Board Advisory Committee Meeting March 31, 2006.
Project Management Basics
Process Understanding and PAT
OPERATIONS MANAGEMENT STRATEGY 1. PRODUCT CHOICE 2. PROCESS CHOICE 3. FACILITIES CHOICE 4. QUALITY CHOICE.
OPERATIONS MANAGEMENT STRATEGY 1. PRODUCT CHOICE 2. PROCESS CHOICE 3. FACILITIES CHOICE 4. QUALITY CHOICE.
A Bayesian approach to the Comparison of NIR vs HPLC analytical methods in Continuous Manufacturing Process Validation Studies Areti Manola1, Jyh-Ming.
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Pharmaceutical Quality Control & current Good Manufacturing Practice
FDA PAT Sub-Committee of Advisory Committee for Pharmaceutical Sciences June 12-13, 2002; Gaithersburg, MD Regulatory Challenges: Post-Approval PAT Applications.
Control-Theoretic Approaches for Dynamic Information Assurance George Vachtsevanos Georgia Tech Working Meeting U. C. Berkeley February 5, 2003.
开发报批美国 FDA 的仿制药 与相关问题探讨 上海复星普适医药科技有限公司何平. 内容提要 开发仿制药的重要性和机遇 开发仿制药的重要性和机遇 开发仿制药的挑战 开发仿制药的挑战 申报仿制药的分类 申报仿制药的分类 仿制药研发团队 仿制药研发团队 仿制药的研发过程 仿制药的研发过程 QbD 在制剂开发中怎么体现.
Portfolio Cases Dom Santucci. AstraZeneca Digital Centre of Excellence Issue: The DCOE site aims to showcase digital capabilities and understanding across.
HOLD-TIME STUDIES.
Manufacturing Simulation Case Studies
CCEA Professional Business Services Workshop#1
LaPTECHNOS & SERVICES IT Services, Product Development
Flexible Containment Concepts in Real Application
Software and Systems Integration
Delivering value from MES: Optimizing Manufacturing Efficiency
Presented by: Ken Glade Director of Engineering
Internal QA in Open Source Development
Presentation transcript:

Bob Chisholm TQMS STATISTICALLY BASED IN-PROCESS CONTROL WITH REAL TIME QUALITY ASSURANCE The AstraZeneca Total Quality Management Strategy R S Chisholm International Technology Manager November 2001

Bob Chisholm TQMS Traditional QA  Validated Processes managed by standard operation procedures  End of Batch off-line QA Testing on a small random sample TQMS  Real Time In Process Monitoring and Control  Real Time Quality Assurance statistically based throughout Batch Manufacture – Increased testing providing the Platform for parametric release

Bob Chisholm TQMS – THE IMPLEMENTATION OF THE STRATEGY Sponsorship by the Senior Executive Team of AZ – THE PARADIGM SHIFT Creation of a Process Analytical Centre of Excellence Integration of TQMS into design of potent product solid dosage facility sanctioned early 1999 in Plankstadt (Germany)  THE PTF PROJECT

Bob Chisholm IMPLEMENTATION OF THE TQM STRATEGY Statistically Based In-process Control & Monitoring Key Process Operations  Identification/specification of all incoming raw materials in the dispensaries (& the warehouse)  Fluid Bed Drier end point control  Continuous in-line monitoring of blending & end point control  In-line monitoring of Tablet Quality Parameters against registered specifications  21CFR11 Compliant data management system  Real-time continuous quality assurance  The Platform for parametric release

Bob Chisholm Quality Control Quality Assurance TQM System Architecture

Bob Chisholm A Solid Dosage Facility FB Drier Milling Blender Press Coater Sieve Dispensary Wet granulationNIRNIR NIR NIR Direct Compression

Bob Chisholm Blend Monitoring Unit

Bob Chisholm Tablet Analyser – Lab based

Bob Chisholm In-line TQMS Tablet Analyser